LM103, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Melanoma Resistant to Standard Therapy

Li Zhou, Xiaojun Cai, Haizhen Du, Xuan Wang, Yue Yang, Zhichao Tan, Jiayong Liu, Zhihong Chi, Lu Si, Lili Mao, Bin Lian, Hui Tian, Qian Guo, Hua Wang, Ming Ji, Lulu Wang, Yuan Yuan, Yongming Xue, Jun Guo, Yan Kong, Chuanliang Cui

Open source

DOI
10.1158/2326-6066.cir-26-0591
Published
2026-11-09
Container
Cancer Immunology Research
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/2326-6066.cir-26-0591,
  title = {LM103, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Melanoma Resistant to Standard Therapy},
  author = {Li Zhou and Xiaojun Cai and Haizhen Du and Xuan Wang and Yue Yang and Zhichao Tan and Jiayong Liu and Zhihong Chi and Lu Si and Lili Mao and Bin Lian and Hui Tian and Qian Guo and Hua Wang and Ming Ji and Lulu Wang and Yuan Yuan and Yongming Xue and Jun Guo and Yan Kong and Chuanliang Cui},
  year = {2026},
  journal = {Cancer Immunology Research},
  doi = {10.1158/2326-6066.cir-26-0591},
  url = {https://doi.org/10.1158/2326-6066.cir-26-0591}
}

RIS

TY  - JOUR
TI  - LM103, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Melanoma Resistant to Standard Therapy
AU  - Li Zhou
AU  - Xiaojun Cai
AU  - Haizhen Du
AU  - Xuan Wang
AU  - Yue Yang
AU  - Zhichao Tan
AU  - Jiayong Liu
AU  - Zhihong Chi
AU  - Lu Si
AU  - Lili Mao
AU  - Bin Lian
AU  - Hui Tian
AU  - Qian Guo
AU  - Hua Wang
AU  - Ming Ji
AU  - Lulu Wang
AU  - Yuan Yuan
AU  - Yongming Xue
AU  - Jun Guo
AU  - Yan Kong
AU  - Chuanliang Cui
PY  - 2026
JO  - Cancer Immunology Research
DO  - 10.1158/2326-6066.cir-26-0591
UR  - https://doi.org/10.1158/2326-6066.cir-26-0591
ER  - 

APA

Zhou, L., Cai, X., Du, H., Wang, X., Yang, Y., Tan, Z., Liu, J., Chi, Z., Si, L., Mao, L., Lian, B., Tian, H., Guo, Q., Wang, H., Ji, M., Wang, L., Yuan, Y., Xue, Y., Guo, J., Kong, Y., & Cui, C. (2026). LM103, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Melanoma Resistant to Standard Therapy. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-26-0591

Source records